It was also important to note that current therapy (i.e. corticosteroids, β-agonists, leukotriene inhibitors, and combinations thereof) was not capable of reducing the frequency of either total CD4+ Tcm or CCR4+ CD4+ Tcm cells in atopic asthma patients. The gene discussed is CCR4; the disease is atopic asthma.